ACCELERON PHARMA INC Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 30.17 | 7,500 | 226,275 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 27.97 | 10,000 | 279,700 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | M | 24.11 | 20,000 | 482,200 | 0 | |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 41.17 | 11,812 | 486,300 | 0 | 11.8 K to 0 (-100.00 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | J | 0.00 | 11,812 | 0 | 11,812 | 0 to 11.8 K |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | J | 0.00 | 11,812 | 0 | 3,750 | 15.6 K to 3.8 K (-75.90 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 39.16 | 25,688 | 1,005,942 | 15,562 | 41.3 K to 15.6 K (-62.27 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 30.17 | 7,500 | 226,275 | 41,250 | 33.8 K to 41.3 K (+22.22 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 27.97 | 10,000 | 279,700 | 33,750 | 23.8 K to 33.8 K (+42.11 %) |
| Jun 28 2019 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Buy | M | 24.11 | 20,000 | 482,200 | 23,750 | 3.8 K to 23.8 K (+533.33 %) |
| Jun 17 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | P | 38.05 | 5,000 | 190,250 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
| Jun 07 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Option Exercise | A | 40.37 | 6,700 | 270,479 | 6,700 | |
| Jun 07 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Grant | A | 0.00 | 1,100 | 0 | 20,731 | 19.6 K to 20.7 K (+5.60 %) |
| Jun 07 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Option Exercise | A | 40.37 | 6,700 | 270,479 | 6,700 | |
| Jun 07 2019 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | VP, General Counsel ... | Grant | A | 0.00 | 1,100 | 0 | 20,731 | 19.6 K to 20.7 K (+5.60 %) |